1,3,4-thiadiazole has been researched along with Hyperlipemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Dujaili, AH; Al-Qirim, TM; Al-Samad, LA; Hamadneh, IM; Hamadneh, LA; Hasan, M; Hikmat, SJ; Sabbah, DA | 1 |
1 other study(ies) available for 1,3,4-thiadiazole and Hyperlipemia
Article | Year |
---|---|
Hypolipidemic effect of novel 2,5-bis(4-hydroxybenzylidenamino)-1,3,4-thiadiazole as potential peroxisome proliferation-activated receptor-α agonist in acute hyperlipidemic rat model.
Topics: Acute Disease; Animals; Disease Models, Animal; Gene Expression Regulation; Hyperlipidemias; Hypolipidemic Agents; Male; PPAR alpha; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiadiazoles | 2019 |